Skip to main content

Advertisement

SpringerLink
Log in

Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis

  • Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Insulin and glucagon are thought to play important roles as hepatotrophic factors in acute viral hepatitis (AVH); however, few reports have investigated the responses and relationships of each of these hormones to liver damage in detail. We studied insulin and glucagon responses during the acute and recovery phases of AVH. We performed a glucose tolerance test (GTT) and an insulin sensitivity test (IST) in each phase in 11 patients with AVH. In 8 additional patients in the acute phase (totaln=19), were compared immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR) levels with transaminase levels. In the acute phase, IRI concentrations were normal from fasting to 60 min, despite an increased CPR level. In the recovery phase, IRI and CPR levels increased significantly. Immunoreactive glucagon levels in both phases did not differ significantly from those in controls. During the IST, the insulin sensitivity index in both phases was significantly lower than that in the controls. Fasting IRI and ΣIRI showed significant negative correlations with transaminase levels. We found enhanced insulin secretion and a decrease in plasma insulin in the acute phase of AVH. The discrepancy between IRI and CPR responses in the acute phase suggests an increase in the degradation or consumption of insulin in the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arne N, Nils A, Lars S, et al. Insulin uptake by the human alcoholic cirrhotic liver. Metabolism 1985;34:48–52.

    Google Scholar 

  2. Kuhl C, Faber O, Hornues P, et al. C-peptide metabolism and the liver. Diabetes 1978;27:197–200.

    PubMed  Google Scholar 

  3. Johnston D, Alberti K, Wright R, et al. C-peptide and insulin in liver disease. Diabetes 1978;27:201–206.

    CAS  PubMed  Google Scholar 

  4. Conn H, Daughaday W. Cirrhosis and diabetes. V. Serum growth hormone levels in Laennec's cirrhosis. J Lab Clin Med 1970;76:678–688.

    CAS  PubMed  Google Scholar 

  5. Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus. In: Lond Progress in liver disease. 1970; 3:371–407.

  6. Greco A, Fedeli G, Ghirlanda G, et al. Behaviour of pancreatic glucagon, insulin and HGH in liver cirrhosis, after arginine and I.V. glucose. Acta Diabetol Lat 1974;11:330–339.

    CAS  PubMed  Google Scholar 

  7. Johnston D, Alberti K. Carbohydrate metabolism in liver disease. J Clin endocrinol and metabol 1976;47:657–702.

    Google Scholar 

  8. Megyesi C, Samols E, Marks V. Glucose intolerance and diabetes in chronic liver disease. Lancet 1967;II:1051–1056.

    Google Scholar 

  9. Collins JR, Lacy WW, Stiel JN, et al. Glucose intolerance and insulin resistance in patients with liver disease. Arch Intern Med 1970;126:608–614.

    Article  CAS  PubMed  Google Scholar 

  10. Proietto J, Alford FP, Cuddley FJ. The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab 1980;51:1030–1036.

    CAS  PubMed  Google Scholar 

  11. Sherwin RS, Fisher M, Bessof J, et al. Hyperglucagonemia in cirrhosis: Altered secretion and sensitivity to glucagon. Gastroenterology 1978;74:1224–1228.

    CAS  PubMed  Google Scholar 

  12. Greco AV, Crucitti F, Ghirlanda G, et al. Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis. Diabetologia 1979;17:23–28.

    Article  CAS  PubMed  Google Scholar 

  13. Smith-Laing G, Orskov H, Gore MBR, et al. Hyperglucagonemia in cirrhosis: Relationship to hepatocellular damage. Diabetologia 1980;19:103–108.

    Article  CAS  PubMed  Google Scholar 

  14. Shinozaki K. Hyperglucagonemia in cirrhosis (in Japanese). Ehime Igaku (Ehime Univ J Med Sci) 1986;5:46–57.

    Google Scholar 

  15. Yoshida T, Mitarai Y, Nagamine K, et al. The implication of hyperglucagonemia and-insulinemia in liver cirrhotics (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1989;86:1273–1280.

    CAS  Google Scholar 

  16. Chupin M, Charbonnel B, Bodic LL, et al. Glucose tolerance in viral hepatitis. Diabetes 1978;27:661–669.

    CAS  PubMed  Google Scholar 

  17. Ohashi K, Senmaru H, Nakabayashi T, et al. Sequence of insulin resistance and insulin receptor (in Japanese with English abstract). Nippon Kanzo Gakkai Zasshi (Acta Hepatol Jpn) 1985;26:305–309.

    Google Scholar 

  18. Park H, Senmaru H, Ohashi K, et al. Increased insulin release from isolated pancreatic islets in D-galactosamine-treated rats. J Clin Exp Tled 1986;136:71–72.

    CAS  Google Scholar 

  19. Sullivan SN, Christofides ND, Bloom SR, et al. The gut hormone profile of fulminant hepatic failure. A J Gastroenterol 1981;76:338–341.

    CAS  Google Scholar 

  20. Hashimoto S, Tubouchi H, Kamibeppu A, et al. Alterations of insulin and glucagon in liver diseases (in Japanese). Kan-tan-sui 1984;8:325–338.

    CAS  Google Scholar 

  21. Bucher NLR, Swaffield MN. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 1975;72:1157–1160.

    CAS  PubMed  Google Scholar 

  22. Okita K. Glucagon-insulin therapy in fulminant hepatitis (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (Gastroenterol Jpn) 1979;14:453–457.

    CAS  Google Scholar 

  23. Richman RE, Claus TH, Pilkis S, et al. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci USA 1976;73:3589–3593.

    CAS  PubMed  Google Scholar 

  24. Okita K, Yasunaga M. Regulation of hepatic regeneration by synergistic action of insulin and glucagon which are known to be peptide-hormone (in Japanese). Kan-tan-sui 1990;21:25–29.

    CAS  Google Scholar 

  25. Andreis PG, Armato U. Effects of epidermal growth factor/urogastrone and associated pancreatic hormones on mitotic cycle phases and proliferation kinetics of neonatal rat hepatocytes in primary culture. Endocrinology 1981;108: 1954–1964.

    CAS  PubMed  Google Scholar 

  26. Martin FIR, Stocks AE. Insulin sensitivity and131I-insulin metabolism in juvenile prediabetes. Aust Ann Med 1967;16: 289–296.

    CAS  PubMed  Google Scholar 

  27. Welch S, Gebhart SSP, Bergman RN et al. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetes subjects. J Clin Endocrinol Metab 1990;71:15608–1518.

    Google Scholar 

  28. Mizuno Y. Insulin sensitivity test. Jpn J Clin Med 1970;28: 2789–2793.

    CAS  Google Scholar 

  29. Takamori S, Takino T, Kanatsuna T, et al. Studies on the abnormalities of carbohydrate metabolism and insulin secretion in liver injuries (in Japanese with English abstract). Nippon Kanzo Gakkai Zasshi (Acta Hepatol Jpn) 1977;18:615–624.

    CAS  Google Scholar 

  30. Johnston DG. Hyperinsulinemia of hepatic cirrhosis; diminished degradation or hypersecretion. Lancet 1977;I:10–13.

    Google Scholar 

  31. Sherwin RS, Fisher M, Bessoff J, et al. Hyperglucagonemia in cirrhosis; altered secretion and sensitivity to glucagon. Gastroenterology 1978;74:1224–1228.

    CAS  PubMed  Google Scholar 

  32. Smith-Laing G. Effects of spontaneous portal-systemic shunting on insulin metabolism. Gastroenterology 1979;76:685–690.

    CAS  PubMed  Google Scholar 

  33. Kimura M. The endocrine function of the pancreas in liver diseases (in Japanese). Mie Igaku (Mie Univ J Med Sci) 1981; 25:97–108.

    Google Scholar 

  34. Lesuiak MA, Roth J. Regulation of receptor concentration by homologous hormones. J Biol Chem 1976;251:3720–3729.

    Google Scholar 

  35. Gavin JR, Roth J, Neville DM, et al. Insulin-dependent regulation of insulin receptor concentrations; a direct demonstration in cell culture. Proc Natl Acad Sci 1974;71:84–88.

    CAS  PubMed  Google Scholar 

  36. Bachmann W, Haslbeck M, Bottger I, et al. Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats. Diabetologia 1979;17:101–109.

    Article  CAS  PubMed  Google Scholar 

  37. Greco AV, Bertoli A, Ghirlanda G, et al. Insulin resistance in liver cirrhosis; decreased insulin binding to circulating monocytes. Horm Metab Res 1980;12:577–581.

    CAS  PubMed  Google Scholar 

  38. Blei AT, Robbins DC, Drobny E, et al. Insulin resistance and insulin receptors in hepatic cirrhosis. Gastroenterology 1982; 83:1191–1199.

    CAS  PubMed  Google Scholar 

  39. Sanuki K. Repair of CCl4-induced liver damage with epidermal growth factor and its biochemical analysis (in Japanese with English abstract). Nippon Kanzo Gakkai Zasshi (Acta Hepatol Jpn) 1988;29:1194–1201.

    Google Scholar 

  40. Nakamura H, Tsubouchi H, Gohda E, et al. Stimulation of DNA synthesis in adult rat hepatocytes in primary culture by sera from patients with fulminant hepatic failure. Biol Med Res 1985;6:231–237.

    Google Scholar 

  41. Tsubouchi H, Niitami Y, Hirano S, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991;13:1–5.

    Article  CAS  PubMed  Google Scholar 

  42. Hamanoue M, Nakamura T. Hepatocyte growth factor (in Japanese). Kan-tan-sui 1990;21:7–10.

    CAS  Google Scholar 

  43. Nancy LR, Bucher NL, Mirian N, et al. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 1975;72:1157–1160.

    Google Scholar 

  44. McGowan JA, Strain AJ, Bucher NL. DNA synthesis in primary cultures of adult rat hepatocytes in a defined medium: Effect of epidermal growth factor, insulin, glucagon, and cyclic-AMP. Cell Physiol 1981;108:353–363.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Showa University School of Medicine, 1-5-8 Hatonodai, Shinagawa-ku, 142, Tokyo, Japan

    Kazuhiro Kaneko, Makoto Arai, Hitoshi Funatomi, Yoshio Hatta & Keiji Mitamura

Authors
  1. Kazuhiro Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Makoto Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hitoshi Funatomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshio Hatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiji Mitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaneko, K., Arai, M., Funatomi, H. et al. Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis. J Gastroenterol 30, 624–631 (1995). https://doi.org/10.1007/BF02367789

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02367789

Key words

Search

Navigation